Haemonetics Corp (HAE)
85.46
+0.54
(+0.64%)
USD |
NYSE |
Nov 21, 16:00
85.46
0.00 (0.00%)
After-Hours: 20:00
Haemonetics Debt to Equity Ratio: 1.394 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.394 |
| June 30, 2024 | 1.352 |
| March 31, 2024 | 0.8415 |
| December 31, 2023 | 0.9229 |
| September 30, 2023 | 0.8529 |
| June 30, 2023 | 0.8847 |
| March 31, 2023 | 0.9363 |
| December 31, 2022 | 0.9881 |
| September 30, 2022 | 1.122 |
| June 30, 2022 | 0.9994 |
| March 31, 2022 | 1.032 |
| December 31, 2021 | 1.064 |
| September 30, 2021 | 1.118 |
| June 30, 2021 | 1.158 |
| March 31, 2021 | 0.9671 |
| December 31, 2020 | 0.4308 |
| September 30, 2020 | 0.6947 |
| June 30, 2020 | 0.868 |
| March 31, 2020 | 0.6515 |
| December 31, 2019 | 0.6469 |
| September 30, 2019 | 0.6354 |
| June 30, 2019 | 0.7373 |
| March 31, 2019 | 0.5242 |
| December 31, 2018 | 0.5346 |
| September 30, 2018 | 0.49 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.5161 |
| March 31, 2018 | 0.3372 |
| December 31, 2017 | 0.3283 |
| September 30, 2017 | 0.3577 |
| June 30, 2017 | 0.3922 |
| March 31, 2017 | 0.4254 |
| December 31, 2016 | 0.4362 |
| September 30, 2016 | 0.518 |
| June 30, 2016 | 0.5586 |
| March 31, 2016 | 0.5654 |
| December 31, 2015 | 0.5936 |
| September 30, 2015 | 0.559 |
| June 30, 2015 | 0.5455 |
| March 31, 2015 | 0.518 |
| December 31, 2014 | 0.5142 |
| September 30, 2014 | 0.5238 |
| June 30, 2014 | 0.5287 |
| March 31, 2014 | 0.5224 |
| December 31, 2013 | 0.542 |
| September 30, 2013 | 0.5831 |
| June 30, 2013 | 0.6206 |
| March 31, 2013 | 0.6242 |
| December 31, 2012 | 0.6192 |
| September 30, 2012 | 0.6239 |
| June 30, 2012 | 0.0067 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4308
Minimum
Dec 2020
1.394
Maximum
Sep 2024
0.9462
Average
0.9517
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5254 |
| Baxter International Inc | 1.643 |
| Globus Medical Inc | 0.1074 |
| ResMed Inc | 0.1304 |
| Integra Lifesciences Holdings Corp | 1.187 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.525B |
| Total Liabilities (Quarterly) | 1.646B |
| Shareholders Equity (Quarterly) | 878.85M |
| Current Ratio | 3.489 |
| Net Debt Paydown Yield | -2.27% |